Steroid hormones and neurosteroids in normal and pathological aging of the nervous system

Progress in Neurobiology

Volumn 71, Issue 1, 2003, Pages 3-29

  Schumacher, M ^a   Weill Engerer, S ^a   Liere, P ^a   Robert, F ^a   Franklin, R J M ^b   Garcia Segura, L M ^c   Lambert, J J ^d   Mayo, W ^a   Melcangi, R C ^e   Parducz, A ^f   Suter, U ^g   Carelli, C ^a   Baulieu, E E ^a   Akwa, Y ^a  

^a INSERM   (France)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c INSTITUTO CAJAL   (Spain)

^d UNIVERSITY OF DUNDEE   (United Kingdom)

^e UNIVERSITY OF MILAN   (Italy)

^f INSTITUTE OF BIOCHEMISTRY   (Hungary)

^g ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

1 PHENYLCYCLOHEXANECARBOXYLIC ACID 2 MORPHOLINOETHYL ESTER; AMYLOID BETA PROTEIN; ANDROGEN; ANTIANDROGEN; ANTIGESTAGEN; AROMATASE INHIBITOR; CONJUGATED ESTROGEN; CORTICOTROPIN; CYTOCHROME P450 ISOENZYME; DEXAMETHASONE; DIZOCILPINE; ESTRADIOL; ESTROGEN; FLUTAMIDE; GESTAGEN; HYDROCORTISONE; MEDROXYPROGESTERONE ACETATE; MIBOLERONE; MIFEPRISTONE; N ALLYLNORMETAZOCINE; NEUROSTEROID; PRASTERONE; PRASTERONE SULFATE; PREGNENOLONE; PREGNENOLONE SULFATE; SCOPOLAMINE; STEROID HORMONE; TAU PROTEIN; TESTOSTERONE; UNINDEXED DRUG;

AGING; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; BRAIN LEVEL; BRAIN REGION; CELL VIABILITY; CEREBELLUM; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CORPUS STRIATUM; DISABILITY; FRONTAL CORTEX; GAS CHROMATOGRAPHY; HIPPOCAMPUS; HORMONAL REGULATION; HORMONE ACTION; HORMONE DEFICIENCY; HORMONE METABOLISM; HORMONE SUBSTITUTION; HUMAN; LEARNING; MASS SPECTROMETRY; MEMORY; MYELINATION; NERVE CELL; NERVE REGENERATION; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM FUNCTION; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; PERIPHERAL NERVE; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; STEROID BLOOD LEVEL; STEROIDOGENESIS;

EID: 10744229403     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2003.09.004     Document Type: Review

References (277)

1. Abraham G.E. Radioimmunoassay of steroids in biological fluids. J. Steroid Biochem. 6:1975;261-270.
2. Akwa Y., Ladurelle N., Covey D.F., Baulieu E.E. The synthetic enantiomer of pregnenolone sulfate is very active on memory in rats and mice, even more so than its physiological neurosteroid counterpart: distinct mechanisms? Proc. Natl. Acad. Sci. U.S.A. 98:2001;14033-14037.
3. Amouyel P. Genetic susceptibility to ageing-associated diseases. C. R. Biol. 325:2002;741-745.
4. Arlt W., Callies F., Allolio B. DHEA replacement in women with adrenal insufficiency: pharmacokinetics, bioconversion and clinical effects on well-being, sexuality and cognition. Endocr. Res. 26:2000;505-511.
5. Asthana S., Craft S., Baker L.D., Raskind M.A., Birnbaum R.S., Lofgreen C.P., Veith R.C., Plymate S.R. Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study. Psychoneuroendocrinology. 24:1999;657-677.
6. Asthana S., Baker L.D., Craft S., Stanczyk F.Z., Veith R.C., Raskind M.A., Plymate S.R. High-dose estradiol improves cognition for women with AD: results of a randomized study. Neurology. 57:2001;605-612.
7. Azcoitia I., Leonelli E., Magnaghi V., Veiga S., Garcia-Segura L.M., Melcangi R.C. Progesterone and its derivatives dihydroprogesterone and tetrahydroprogesterone reduce myelin fiber morphological abnormalities and myelin fiber loss in the sciatic nerve of aged rats. Neurobiol. Aging. 24:2003;853-860.
8. Balthazart J., Ball G.F. New insights into the regulation and function of brain estrogen synthase (aromatase). Trends Neurosci. 21:1998;243-249.
9. Barham M. Selective estrogen-receptor modulators. N. Engl. J. Med. 348:2003;2259.
10. Barrett-Connor E., Edelstein S.L. A prospective study of dehydroepiandrosterone sulfate and cognitive function in an older population: the Rancho Bernardo Study. J. Am. Geriatr. Soc. 42:1994;420-423.
11. Barrett-Connor E., Slone S., Greendale G., Kritz-Silverstein D., Espeland M., Johnson S.R., Waclawiw M., Fineberg S.E. The Postmenopausal Estrogen/Progestin Interventions Study: primary outcomes in adherent women. Maturitas. 27:1997;261-274.
12. Baulieu E.E. Neurosteroids: a new function in the brain. Biol. Cell. 71:1991;3-10.
13. Baulieu E.E. Neurosteroids: of the nervous system, by the nervous system, for the nervous system. Recent Prog. Horm. Res. 52:1997;1-32.
14. Baulieu, E.E., Robel, P., Schumacher, M., 1999. Neurosteroids. A New Regulatory Function in the Nervous System. Humana Press, Totowa, NJ.
15. Baulieu E.E., Thomas G., Legrain S., Lahlou N., Roger M., Debuire B., Faucounau V., Girard L., Hervy M.P., Latour F., Leaud M.C., Mokrane A., Pitti-Ferrandi H., Trivalle C., de Lacharrière O., Nouveau S., Rakoto-Arison B., Souberbielle J.C., Raison J., Le Bouc Y., Raynaud A., Girerd X., Forette F. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proc. Natl. Acad. Sci. U.S.A. 97:2000;4279-4284.
16. Baulieu E.E., Robel P., Schumacher M. Neurosteroids: beginning of the story. Int. Rev. Neurobiol. 46:2001;1-32.
17. Behl C., Skutella T., Lezoualc'h F., Post A., Widmann M., Newton C.J., Holsboer F. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol. Pharmacol. 51:1997;535-541.
18. Belanger A., Candas B., DuPont A., Cusan L., Diamond P., Gomez J.L., Labrie F. Changes in serum concentrations of conjugated and unconjugated steroids in 40-80-year-old men. J. Clin. Endocrinol. Metab. 79:1994;1086-1090.
19. Bellino, F.L., Daynes, R.A., Hornsby, P.J., Lavrin, D.H., Nestler, J.E., 1995. Dehydroepiandrosterone (DHEA) and Aging, vol. 774. New York Academy of Sciences, New York.
20. Beyenburg S., Stoffel-Wagner B., Watzka M., Blumcke I., Bauer J., Schramm J., Bidlingmaier F., Elger C.E. Expression of cytochrome P450scc mRNA in the hippocampus of patients with temporal lobe epilepsy. Neuroreport. 10:1999;3067-3070.
21. Beyenburg S., Watzka M., Blumcke I., Schramm J., Bidlingmaier F., Elger C.E., Stoffel-Wagner B. Expression of mRNAs encoding for 17beta-hydroxisteroid dehydrogenase isozymes 1, 2, 3 and 4 in epileptic human hippocampus. Epilepsy Res. 41:2000;83-91.
22. Beyenburg S., Watzka M., Clusmann H., Blumcke I., Bidlingmaier F., Elger C.E., Stoffel-Wagner B. Messenger RNA of steroid 21-hydroxylase (CYP21) is expressed in the human hippocampus. Neurosci. Lett. 308:2001;111-114.
23. Bitran D., Foley M., Audette D., Leslie N., Frye C.A. Activation of peripheral mitochondrial benzodiazepine receptors in the hippocampus stimulates allopregnanolone synthesis and produces anxiolytic-like effects in the rat. Psychopharmacology. 151:2000;64-71.
24. Bixo M., Backstrom T., Winblad B., Andersson A. Estradiol and testosterone in specific regions of the human female brain in different endocrine states. J. Steroid Biochem. Mol. Biol. 55:1995;297-303.
25. Bixo M., Andersson A., Winblad B., Purdy R.H., Bäckström T. Progesterone, 5alpha-pregnane-320-dione and 3alpha-hydroxy-5alpha-pregnane-20- one in specific regions of the human female brain in different endocrine states. Brain Res. 764:1997;173-178.
26. Bjorn I., Bixo M., Nojd K.S., Collberg P., Nyberg S., Sundstrom P., Backstrom T. The impact of different doses of medroxyprogesterone acetate on mood symptoms in sequential hormonal therapy. Gynecol. Endocrinol. 16:2002;1-8.
27. Bologa L., Sharma J., Roberts E. Dehydroepiandrosterone and its sulfated derivative reduce neuronal death and enhance astrocytic differentiation in brain cell cultures. J. Neurosci. Res. 17:1987;225-234.
28. Brenner D.E., Kukull W.A., Stergachis A., van Belle G., Bowen J.D., McCormick W.C., Teri L., Larson E.B. Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study. Am. J. Epidemiol. 140:1994;262-267.
29. Brown R.C., Cascio C., Papadopoulos V. Pathways of neurosteroid biosynthesis in cell lines from human brain: regulation of dehydroepiandrosterone formation by oxidative stress and beta-amyloid peptide. J. Neurochem. 74:2000;847-859.
30. Bullock L.P., Bardin C.W., Sherman M.R. Androgenic, antiandrogenic, and synandrogenic actions of progestins: role of steric and allosteric interactions with androgen receptors. Endocrinology. 103:1978;1768-1782.
31. Burger H.G., Dudley E.C., Robertson D.M., Dennerstein L. Hormonal changes in the menopause transition. Recent Prog. Horm. Res. 57:2002;257-275.
32. Buster J.E., Abraham G.E. The applications of steroid hormone radioimmunoassays to clinical obstetrics. Obstet. Gynecol. 46:1975;489-499.
33. Callier S., Morissette M., Grandbois M., Di Paolo T. Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice. Synapse. 37:2000;245-251.
34. Cardona-Gomez G.P., Mendez P., Doncarlos L.L., Azcoitia I., Garcia-Segura L.M. Interactions of estrogens and insulin-like growth factor-I in the brain: implications for neuroprotection. Brain Res. Rev. 37:2001;320-334.
35. Cardounel A., Regelson W., Kalimi M. Dehydroepiandrosterone protects hippocampal neurons against neurotoxin-induced cell death: mechanism of action. Soc. Exp. Biol. Med. 222:1999;145-149.
36. Carlson L.E., Sherwin B.B. Relationships among cortisol (CRT), dehydroepiandrosterone-sulfate (DHEAS), and memory in a longitudinal study of healthy elderly men and women. Neurobiol. Aging. 20:1999;315-324.
37. Carlson J.L., Martin P.M., de Launoit Y. Characterization of 17beta-hydroxysteroid dehydrogenase activity and mRNA abundance in human meningioma tumors. Neuroendocrinology. 60:1994;445-451.
38. Carlson L.E., Sherwin B.B., Chertkow M.H. Relationship between dehydroepiandrosterone sulfate (DHEAS) and cortisol (CRT) plasma levels and everyday memory in Alzheimer's disease patients compared to healthy controls. Horm. Behav. 35:1999;254-263.
39. Carroll B.J., Heath B., Jarrett D.B. Corticosteroids in brain tissue. Endocrinology. 97:1975;290-300.
40. Cascio C., Brown R.C., Liu Y., Han Z., Hales D.B., Papadopoulos V. Pathways of dehydroepiandrosterone formation in rat brain glia. J. Steroid Biochem. Mol. Biol. 75:2000;177-186.
41. Chan J.R., Phillips L.J., Glaser M. Glucocorticoids and progestins signal the initiation and enhance the rate of myelin formation. Proc. Natl. Acad. Sci. U.S.A. 95:1998;10459-10464.
42. Chen Z., Yuhanna I.S., Galcheva-Gargova Z., Karas R.H., Mendelsohn M.E., Shaul P.W. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J. Clin. Invest. 103:1999;401-406. (published erratum appeared in 1999 in J. Clin. Invest. 103 (9), 1363).
43. Cheney D.L., Uzunov D., Costa E., Guidotti A. Gas chromatographic-mass fragmentographic quantitation of 3alpha-hydroxy-5alpha-pregnan-20-one (allopregnanolone) and its precursors in blood and brain of adrenalectomized and castrated rats. J. Neurosci. 15:1995;4641-4650.
44. Chwalisz K., Garg R., Brenner R.M., Schubert G., Elger W. Selective progesterone receptor modulators (SPRMs): a novel therapeutic concept in endometriosis. Ann. N. Y. Acad. Sci. 955:2002;373-388.
45. Civic D., Scholes D., Ichikawa L., Lacroix A.Z., Yoshida C.K., Ott S.M., Barlow W.E. Depressive symptoms in users and non-users of depot medroxyprogesterone acetate. Contraception. 61:2000;385-390.
46. Compagnone N.A., Mellon S.H. Dehydroepiandrosterone: a potential signalling molecule for neocortical organization during development (see comments). Proc. Natl. Acad. Sci. U.S.A. 95:1998;4678-4683.
47. Corpéchot C., Robel P., Lachapelle F., Baumann N., Axelson M., Sjovall J., Baulieu E.E. Dehydroepiandrosterone libre et sulfo-conjugee dans le cerveau de souris dysmyeliniques. C. R. Acad. Sci. Paris. 292:1981;231-234.
48. Costa M.M., Reus V.I., Wolkowitz O.M., Manfredi F., Lieberman M. Estrogen replacement therapy and cognitive decline in memory-impaired post-menopausal women. Biol. Psychiatry. 46:1999;182-188.
49. Covey D.F., Nathan D., Kalkbrenner M., Nilsson K.R., Hu Y., Zorumski C.F., Evers A.S. Enantioselectivity of pregnanolone-induced gamma-aminobutyric acid(A) receptor modulation and anesthesia. J. Pharmacol. Exp. Ther. 293:2000;1009-1016.
50. Culty M., Li H., Boujrad N., Amri H., Vidic B., Bernassau J.M., Reversat J.L., Papadopoulos V. In vitro studies on the role of the peripheral-type benzodiazepine receptor in steroidogenesis. J. Steroid Biochem. Mol. Biol. 69:1999;123-130.
51. Cunningham C.J., Sinnott M., Denihan A., Rowan M., Walsh J.B., O'Moore R., Coakley D., Coen R.F., Lawler B.A., O'Neill D.D. Endogenous sex hormone levels in postmenopausal women with Alzheimer's disease. J. Clin. Endocrinol. Metab. 86:2001;1099-1103.
52. Darnaudéry M., Koehl M., Pallarés M., Le Moal M., Mayo W. The neurosteroid pregnenolone sulfate increases cortical acetylcholine release: a microdialysis study in freely moving rats. J. Neurochem. 71:1998;2018-2022.
53. Davis S. Androgen replacement in women: a commentary. J. Clin. Endocrinol. Metab. 84:1999;1886-1891.
54. De Vries G.J., Wang Z., Bullock N.A., Numan S. Sex differences in the effects of testosterone and its metabolites on vasopressin messenger RNA levels in the bed nucleus of the stria terminalis of rats. J. Neurosci. 14(Part 2):1994;1789-1794.
55. Dhandapani K.M., Brann D.W. Protective effects of estrogen and selective estrogen receptor modulators in the brain. Biol. Reprod. 67:2002;1379-1385.
56. Dubal D.B., Wise P.M. Neuroprotective effects of estradiol in middle-aged female rats. Endocrinology. 142:2001;43-48.
57. Ferrario E., Massaia M., Aimo G., di Ceva P.A., Fabris F. Dehydroepiandrosterone sulfate serum levels: no significance in diagnosing Alzheimer's disease. J. Endocrinol. Invest. 22:1999;81.
58. Ferreira A., Caceres A. Estrogen-enhanced neurite growth: evidence for a selective induction of tau and stable microtubules. J. Neurosci. 11:1991;392-400.
59. Fillenbaum G.G., Hanlon J.T., Landerman L.R., Schmader K.E. Impact of estrogen use on decline in cognitive function in a representative sample of older community-resident women. Am. J. Epidemiol. 153:2001;137-144.
60. Flood J.F., Roberts E. Dehydroepiandrosterone sulfate improves memory in aging mice. Brain Res. 448:1988;178-181.
61. Flood J.F., Morley J.E., Roberts E. Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it. Proc. Natl. Acad. Sci. U.S.A. 89:1992;1567-1571.
62. Flood J.F., Morley J.E., Roberts E. Pregnenolone sulfate enhances post-training memory processes when injected in very low doses into limbic system structures: the amygdala is by far the most sensitive. Proc. Natl. Acad. Sci. U.S.A. 92:1995;10806-10810.
63. Garcia-Segura L.M., Wozniak A., Azcoitia I., Rodriguez J.R., Hutchison R.E., Hutchison J.B. Aromatase expression by astrocytes after brain injury: implications for local estrogen formation in brain repair. Neuroscience. 89:1999;567-578.
64. Garcia-Segura L.M., Azcoitia I., Doncarlos L.L. Neuroprotection by estradiol. Prog. Neurobiol. 63:2001;29-60.
65. Genazzani A.D., Petraglia F., Bernardi F., Casarosa E., Salvestroni C., Tonetti A., Nappi R.E., Luisi S., Palumbo M., Purdy R.H., Luisi M. Circulating levels of alloprenanolone in humans: gender, age and endocrine influences. J. Clin. Endocrinol. Metab. 83:2002;2099-2103.
66. Ghoumari A.M., Ibanez C., el-Etr M., Leclerc P., Eychenne B., Baulieu E.E., Schumacher M. Progesterone and its metabolites increase myelin basic protein expression in organotypic slice cultures of rat cerebellum. J. Neurochem. 86:2003;848-859.
67. Gomez-Isla T., Price J.L., McKeel D.W., Morris J.C., Growdon J.H., Hyman B.T. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J. Neurosci. 16:1996;4491-4500.
68. Gonzalez Deniselle M.C., Lopez-Costa J.J., Saavedra J.P., Pietranera L., Gonzalez S.L., Garay L., Guennoun R., Schumacher M., Denicola A.F. Progesterone neuroprotection in the wobbler mouse, a genetic model of spinal cord motor disease. Neurobiol. Dis. 11:2002;457-468.
69. Goodman Y., Bruce A.J., Cheng B., Mattson M.P. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J. Neurochem. 66:1996;1836-1844.
70. Gould E., Tanapat P., Rydel T., Hastings N. Regulation of hippocampal neurogenesis in adulthood. Biol. Psychiatry. 48:2000;715-720.
71. Gouras G.K., Xu H., Gross R.S., Greenfield J.P., Hai B., Wang R., Greengard P. Testosterone reduces neuronal secretion of Alzheimer's beta-amyloid peptides. Proc. Natl. Acad. Sci. U.S.A. 97:2000;1202-1205.
72. Green P.S., Perez E.J., Calloway T., Simpkins J.W. Estradiol attenuation of beta-amyloid-induced toxicity: a comparison of MTT and calcein AM assays. J. Neurocytol. 29:2000;419-423.
73. Gursoy E., Cardounel A., Kalimi M. Pregnenolone protects mouse hippocampal (HT-22) cells against glutamate and amyloid beta protein toxicity. Neurochem. Res. 26:2001;15-21.
74. Gutai J.P., Meyer W.J., Kowarski A.A., Migeon C.J. Twenty-four-hour integrated concentrations of progesterone, 17-hydroxyprogesterone and cortisol in normal male subjects. J. Clin. Endocrinol. Metab. 44:1977;116-120.
75. Guth L., Zhang Z., Roberts E. Key role for pregnenolone in combination therapy promotes recovery after spinal cord injury. Proc. Natl. Acad. Sci. U.S.A. 91:1994;12308-12312.
76. Hammond G.L., Hirvonen J., Vihko R. Progesterone, androstenedione, testosterone, 5alpha-dihydrotestosterone and androsterone concentrations in specific regions of the human brain. J. Steroid Biochem. 18:1983;185-189.
77. Hammond J., Le Q., Goodyer C., Gelfand M., Trifiro M., LeBlanc A. Testosterone-mediated neuroprotection through the androgen receptor in human primary neurons. J. Neurochem. 77:2001;1319-1326.
78. Hampl R., Morfin R., Starka L. Minireview: 7-hydroxylated derivatives of dehydroepiandrosterone. What are they good for? Endocr. Regul. 31:1997;211-218.
79. Hauw J.J., Duyckaerts C. Dementia, the fate of the brain? Neuropathological point of view. C. R. Biol. 325:2002;655-664.
80. Hebert L.E., Beckett L.A., Scherr P.A., Evans D.A. Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050. Alzheimer Dis. Assoc. Disord. 15:2001;169-173.
81. Henderson V.W., Paganini-Hill A., Emanuel C.K., Dunn M.E., Buckwalter J.G. Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects. Arch. Neurol. 51:1994;896-900.
82. Henderson V.W., Paganini-Hill A., Miller B.L., Elbe R.J., Reyes P.F., Shoupe D., McCleary C.A., Klein R.A., Hake A.M., Farlow M.R. Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial. Neurology. 54:2000;295-301.
83. Henzl, M.R., Edwards, J.A., 2000. Pharmacology of progestins: 17alpha-hydroxyprogesterone derivatives and progestins of the first and second generation. In: Sitruk-Ware, R., Mishell, D.R. (Eds.), Progestins and Antiprogestins in Clinical Practice. Marcel Dekker, New York, pp. 101-132.
84. Herbert J. The age of dehydroepiandrosterone. Lancet. 345:1995;1193-1194.
85. Hill M., Lukac D., Lapcik O., Sulcova J., Hampl R., Pouzar V., Starka L. Age relationships and sex differences in serum levels of pregnenolone and 17-hydroxypregnenolone in healthy subjects. Clin. Chem. Lab. Med. 37:1999;439-447.
86. Hutchison J.B., Steimer T. Brain 5β-reductase: a correlate of behavioral sensitivity to androgen. Science. 213:1981;244-246.
87. Ibanez, C., Shields, S.A., Liere, P., el-Etr, M., Baulieu, E.E., Schumacher, M., Franklin, R.J.M. Systemic progesterone administration results in a partial reversal of the age-associated decline in CNS remyelination following toxin-induced demyelination in male rats. Neuropathol. Appl. Neurobiol., in press.
88. Inoue T., Akahira J., Suzuki T., Darnel A.D., Kaneko C., Takahashi K., Hatori M., Shirane R., Kumabe T., Kurokawa Y., Satomi S., Sasano H. Progesterone production and actions in the human central nervous system and neurogenic tumors. J. Clin. Endocrinol. Metab. 87:2002;5325-5331.
89. Isaacson R.L., Varner J.A., Baars J.M., De Wied D. The effects of pregnenolone sulfate and ethylestrenol on retention of a passive avoidance task. Brain Res. 689:1995;79-84.
90. Ishida Y., Ishida Y., Heersche J.N. Pharmacologic doses of medroxyprogesterone may cause bone loss through glucocorticoid activity: an hypothesis. Osteoporos. Int. 13:2002;601-605.
91. Jacobs D.M., Tang X.M., Stern Y., Sano M., Marder K., Bell K.L., Schofield P., Dooneief G., Gurland B., Mayeux R. Cognitive function in nondemented older women who took estrogen after menopause. Neurology. 50:1998;368-373.
92. Janowsky J.S., Oviatt S.K., Orwoll E.S. Testosterone influences spatial cognition in older men. Behav. Neurosci. 108:1994;325-332.
93. 14C ]testosterone by human foetal and adult brain tissue J. Endocrinol. 74:1977;425-429.
94. Jiang N., Chopp M., Stein D.G., Feldblum S. Progesterone is neuroprotective after transient middle cerebral artery occlusion in male rats. Brain Res. 735:1996;101-107.
95. Johnson A.E., Coirini H., McEwen B.S., Insel T.R. Testosterone modulates oxytocin binding in the hypothalamus of castrated male rats. Neuroendocrinology. 50:1989;199-203.
96. Johnson D.A., Rhodes M.E., Boni R.L., Li P.K. Chronic steroid sulfatase inhibition by (p-O-sulfamoyl)-N-tetradecanoyl tyramine increases dehydroepiandrosterone sulfate in whole brain. Life Sci. 61:1997;L.
97. Jones K.J., Brown T.J., Damaser M. Neuroprotective effects of gonadal steroids on regenerating peripheral motoneurons. Brain Res. Rev. 37:2001;372-382.
98. Kalimi, M., Regelson, W., 1990. The Biological Role of Dehydroepiandrosterone. Walter de Gruyter, Berlin.
99. Kalmijn S., Launer L.J., Stolk R.P., De Jong F.H., Pols H.A., Hofman A., Breteler M.M., Lamberts S.W. A prospective study on cortisol, dehydroepiandrosterone sulfate, and cognitive function in the elderly. J. Clin. Endocrinol. Metab. 83:1998;3487-3492.
100. Karishma K.K., Herbert J. Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone-induced suppression. Eur. J. Neurosci. 16:2002;445-453.
101. Kawano H., Motoyama T., Hirai N., Yoshimura T., Kugiyama K., Ogawa H., Okamura H., Yasue H. Effect of medroxyprogesterone acetate plus estradiol on endothelium-dependent vasodilation in postmenopausal women. Am. J. Cardiol. 87:2001;238-240.
102. Kawas C., Resnick S., Morrison A., Brookmeyer R., Corrada M., Zonderman A., Bacal C., Lingle D.D., Metter E. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology. 48:1997;1517-1521. (published erratum appeared in 1998 in Neurology 51 (2), 654).
103. Khaw K.T. Epidemiology of the menopause. Br. Med. Bull. 48:1992;249-261.
104. Kimonides V.G., Spilantini M.G., Sofroniew M.V., Fawcett J.W., Herbert J. Dehydroepiandrosterone antagonizes the neurotoxic effects of corticosterone and translocation of stress-activated protein kinase 3 in hippocampal primary cultures. Neuroscience. 89:1999;429-436.
105. Knapstein P., David A., Wu C.H., Archer D.F., Flickinger G.L., Tochstone J.C. Metabolism of free and sulfoconjugated DHEA in brain tissue in vivo and in vitro. Steroids. 11:1968;885-896.
106. Koenig H., Schumacher M., Ferzaz B., Do Thi A.N., Ressouches A., Guennoun R., Jung-Testas I., Robel P., Akwa Y., Baulieu E.E. Progesterone synthesis and myelin formation by Schwann cells. Science. 268:1995;1500-1503.
107. Korneyev A., Pan B.S., Polo A., Romeo E., Guidotti A., Costa E. Stimulation of brain pregnenolone synthesis by mitochondrial diazepam binding inhibitor receptor ligands in vivo. J. Neurochem. 61:1993;1515-1524.
108. Krishnan V., Heath H., Bryant H.U. Mechanism of action of estrogens and selective estrogen receptor modulators. Vitam. Horm. 60:2000;123-147.
109. Labrie F., Belanger A., Cusan L., Gomez J.L., Candas B. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J. Clin. Endocrinol. Metab. 82:1997a;2396-2402.
110. Labrie F., Bélanger A., Cusan L., Candas B. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology. J. Clin. Endocrinol. Metab. 82:1997b;2403-2409.
111. Lachance Y., Luu-The V., Labrie C., Simard J., Dumont M., de Launoit Y., Guerin S., LeBlanc G., Labrie F. Characterization of human 3beta-hydroxysteroid dehydrogenase/delta5-delta4-isomerase gene and its expression in mammalian cells. J. Biol. Chem. 265:1990;20469-20475. (published erratum appeared in 1992 in J. Biol. Chem. 267 (5), 3551).
112. Lachance Y., Luu-The V., Verreault H., Dumont M., Rheaume E., LeBlanc G., Labrie F. Structure of the human type II 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase (3beta-HSD) gene: adrenal and gonadal specificity. DNA Cell Biol. 10:1991;701-711.
113. Lacroix C., Fiet J., Benais J.P., Gueux B., Bonete R., Villette J.M., Gourmel B., Dreux C. Simultaneous radioimmunoassay of progesterone, androst-4-enedione, pregnenolone, dehydroepiandrosterone and 17-hydroxyprogesterone in specific regions of human brain. J. Steroid Biochem. 28:1987;317-325.
114. Ladurelle N., Eychenne B., Denton D., Blair-West J., Schumacher M., Robel P., Baulieu E.E. Prolonged intracerebroventricular infusion of neurosteroids affects cognitive performances in the mouse. Brain Res. 858:2000;371-379.
115. Lamberts S.W., van den Beld A.W., van der Lely A.J. The endocrinology of aging (see comments). Science. 278:1997;419-424.
116. Lanthier A., Patwardhan V.V. Sex steroids and 5-en-3beta-hydroxysteroids in specific regions of the human brain and cranial nerves. J. Steroid Biochem. 25:1986;445-449.
117. Lathe R. Steroid and sterol 7-hydroxylation: ancient pathways. Steroids. 67:2002;967-977.
118. Laughlin G.A., Barrett-Connor E. Sexual dimorphism in the influence of advanced aging on adrenal hormone levels: the Rancho Bernardo Study. J. Clin. Endocrinol. Metab. 85:2000;3561-3568.
119. Leblhuber F., Neubauer C., Peichl M., Reisecker F., Steinparz F.X., Windhager E., Dienstl E. Age and sex differences of dehydroepiandrosterone sulfate (DHEAS) and cortisol (CRT) plasma levels in normal controls and Alzheimer's disease (AD). Psychopharmacology. 111:1993;23-26.
120. Le Fur G., Guillot F., Alexander J., Muller J.C. Research strategies in the pharmaceutical industry to cope with problems of ageing. C. R. Biol. 325:2002;643-654.
121. Le Goascogne C., Gouézou M., Robel P., Defaye G., Chambaz E., Waterman M.R., Baulieu E.E. The cholesterol side-chain cleavage complex in human brain white matter. J. Neuroendocrinol. 1:1989;153-156.
122. Legrain S., Berr C., Frenoy N., Gourlet V., Debuire B., Baulieu E.E. Dehydroepiandrosterone sulfate in a long-term care aged population. Gerontology. 41:1995;343-351.
123. Li P.K., Rhodes M.E., Jagannathan S., Johnson D.A. Reversal of scopolamine induced amnesia in rats by the steroid sulfatase inhibitor estrone-3-O-sulfamate. Brain Res. Cogn. Brain Res. 2:1995;251-254.
124. Li P.K., Rhodes M.E., Burke A.M., Johnson D.A. Memory enhancement mediated by the steroid sulfatase inhibitor (p-O-sulfamoyl)-N-tetradecanoyl tyramine. Life Sci. 60:1997;L45-L51.
125. Liere P., Akwa Y., Weill E., Eychenne B., Pianos A., Robel P., Sjovall J., Schumacher M., Baulieu E.E. Validation of an analytical procedure to measure trace amounts of neurosteroids in brain tissue by gas chromatography-mass spectrometry. J. Chromatogr. B: Biomed. Sci. Appl. 739:2000;301-312.
126. Littleton K., Ostrowski N.L., Cox D.A., Rossberg M.I., Hurn P.D. Selective estrogen receptor modulators: tissue actions and potential for CNS protection. CNS Drug Rev. 8:2002;309-330.
127. Lorenzo A., Diaz H., Carrer H., Caceres A. Amygdala neurons in vitro - neurite growth and effects of estradiol. J. Neurosci. Res. 33:1992;418-435.
128. Loria R.M. Immune up-regulation and tumor apoptosis by androstene steroids. Steroids. 67:2002;953-966.
129. Lupien S.J., De Leon M., de Santi S., Convit A., Tarshish C., Nair N.P., Thakur M., McEwen B.S., Hauger R.L., Meaney M.J. Cortisol levels during human aging predict hippocampal atrophy and memory deficits (see comments). Nat. Neurosci. 1:1998;69-73. (published erratum appeared in 1998 in Nat. Neurosci. 1 (4), 329).
130. Lupien S.J., Nair N.P., Briere S., Maheu F., Tu M.T., Lemay M., McEwen B.S., Meaney M.J. Increased cortisol levels and impaired cognition in human aging: implication for depression and dementia in later life. Rev. Neurosci. 10:1999;117-139.
131. Maggi R., Poletti A., Casulari L.A., Pimpinelli F., Piva F., Zanisi M.R., Martini L. Effects and metabolism of steroid hormones in human neuroblastoma cells. Steroids. 63:1998;257-262.
132. Magnaghi V., Cavarretta I., Zucchi I., Susani L., Rupprecht R., Hermann B., Martini L., Melcangi R.C. Po gene expression is modulated by androgens in the sciatic nerve of adult male rats. Mol. Brain Res. 70:1999;36-44.
133. Magnaghi V., Cavarretta I., Galbiati M., Martini L., Melcangi R.C. Neuroactive steroids and peripheral myelin proteins. Brain Res. Brain Res. Rev. 37:2001;360-371.
134. Malsbury C.W., McKay K. Neurotrophic effects of testosterone on the medial nucleus of the amygdala in adult male rats. J. Neuroendocrinol. 6:1994;57-69.
135. Manly J.J., Merchant C.A., Jacobs D.M., Small S.A., Bell K., Ferin M., Mayeux R. Endogenous estrogen levels and Alzheimer's disease among postmenopausal women. Neurology. 54:2000;833-837.
136. Mathis C., Paul S.M., Crawley J.N. The neurosteroid pregnenolone sulfate blocks NMDA antagonist-induced deficits in a passive avoidance memory task. Psychopharmacology. 116:1994;201-206.
137. Mathis C., Vogel E., Cagniard B., Criscuolo F., Ungerer A. The neurosteroid pregnenolone sulfate blocks deficits induced by a competitive NMDA antagonist in active avoidance and lever-press learning tasks in mice. Neuropharmacology. 35:1996;1057-1064.
138. Mathur R.S., Landgrebe S.C., Moody L.O., Semmens J.P., Williamson H.O. The effect of estrogen treatment on plasma concentrations of steroid hormones, gonadotropins, prolactin and sex hormone-binding globulin in post-menopausal women. Maturitas. 7:1985;129-133.
139. Mathur C., Prasad V.V.K., Raju V.S., Welch M., Lieberman S. Steroids and their conjugates in the mammalian brain. Proc. Natl. Acad. Sci. U.S.A. 90:1993;85-88.
140. Matsunaga M., Ukena K., Tsutsui K. Expression and localization of cytochrome P450 17alpha-hydroxylase/c17,20-lyase in the avian brain. Brain Res. 899:2001;112-122.
141. Maurice T., Junien J.L., Privat A. Dehydroepiandrosterone sulfate attenuates dizocilpine-induced learning impairment in mice via sigma 1-receptors. Behav. Brain Res. 83:1997;159-164.
142. Maurice T., Su T.P., Privat A. Sigma1 (σ1) receptor agonists and neurosteroids attenuate B25-35-amyloid peptide-induced amnesia in mice through a common mechanism. Neuroscience. 83:1998;413-428.
143. Mayo W., Dellu F., Robel P., Cherkaoui J., Le Moal M., Baulieu E.E., Simon H. Infusion of neurosteroids into the nucleus basalis magnocellularis affects cognitive processes in the rat. Brain Res. 607:1993;324-328.
144. Mazat L., Lafont S., Debuire B., Tessier J.F., Dartigues J.F., Baulieu E.E. Prospective measurements of dehydroepiandrosterone sulfate in a cohort of elderly subjects: relationship, to gender, subjective health, smoking habits, and 10-year mortality. Proc. Natl. Acad. Sci. U.S.A. 98:2001;8145-8150.
145. McEwen B.S. Invited review: estrogens effects on the brain: multiple sites and molecular mechanisms. J. Appl. Physiol. 91:2001;2785-2801.
146. McEwen B.S., De Leon M.J., Lupien S.J., Meaney M.J. Corticosteroids, the aging brain and cognition. Trends Endocrinol. Metab. 10:1999;92-96.
147. McIntosh M.K., Pan J.S., Berdanier C.D. In vitro studies on the effects of dehydroepiandrosterone and corticosterone on hepatic-steroid receptor-binding and mitochondrial respiration. Comp. Biochem. Physiol. 104:1993;147-153.
148. McNeill A.M., Zhang C., Stanczyk F.Z., Duckles S.P., Krause D.N. Estrogen increases endothelial nitric oxide synthase via estrogen receptors in rat cerebral blood vessels: effect preserved after concurrent treatment with medroxyprogesterone acetate or progesterone. Stroke. 33:2002;1685-1691.
149. Melcangi R.C., Magnaghi V., Cavarretta I., Martini L., Piva F. Age-induced decrease of glycoprotein Po and myelin basic protein gene expression in the rat sciatic nerve. Repair by steroid derivatives. Neuroscience. 85:1998a;569-578.
150. Melcangi R.C., Magnaghi V., Cavarretta I., Riva M.A., Piva F., Martini L. Effects of steroid hormones on gene expression of glial markers in the central and peripheral nervous system: variations induced by aging. Exp. Gerontol. 33:1998b;827-836.
151. Melcangi R.C., Magnaghi V., Cavarretta I., Zucchi I., Bovolin P., D'Urso D., Martini L. Progesterone derivatives are able to influence peripheral myelin protein 22 and P0 gene expression: possible mechanisms of action. J. Neurosci. Res. 56:1999;349-357.
152. Mellon S.H., Miller W.L. Extraadrenal steroid 21-hydroxylation is not mediated by P450c21. J. Clin. Invest. 84:1989;1497-1502.
153. Mellon S.H., Vaudry H. Biosynthesis of neurosteroids and regulation of their synthesis. Int. Rev. Neurobiol. 46:2001;33-78.
154. Mellon S.H., Griffin L.D., Compagnone N.A. Biosynthesis and action of
155. Mensah-Nyagan A.G., Do-Rego J.L., Beaujean D., Luu-The V., Pelletier G., Vaudry H. Neurosteroids: expression of steroidogenic enzymes and regulation of steroid biosynthesis in the central nervous system. Pharmacol. Rev. 51:1999;63-81.
156. Meziane H., Mathis C., Paul S.M., Ungerer A. The neurosteroid pregnenolone sulfate reduces learning deficits induced by scopolamine and has promnestic effects in mice performing an appetitive learning task. Psychopharmacology (Berl). 126:1996;323-330.
157. Miyagawa K., Rosch J., Stanczyk F., Hermsmeyer K. Medroxyprogesterone interferes with ovarian steroid protection against coronary vaso spasm. Nat. Med. 3:1997;324-327.
158. Morales A.J., Nolan J.J., Nelson J.C., Yen S.S.C. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J. Clin. Endocrinol. Metab. 78:1994;1360-1367.
159. Morales A.J., Haubrich R.H., Hwang J.Y., Asakura H., Yen S.S. The effect of six months treatment with 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clin. Endocrinol. 49:1998;421-432.
160. Morfin R., Young J., Corpechot C., Egestad B., Sjovall J., Baulieu E.E. Neurosteroids: pregnenolone in human sciatic nerves. Proc. Natl. Acad. Sci. U.S.A. 89:1992;6790-6793.
161. Morfin R., Lafaye P., Cotillon A.C., Nato F., Chmielewski V., Pompon D. 7Alpha-hydroxy-dehydroepiandrosterone and immune response. Ann. N. Y. Acad. Sci. 917:2000;971-982.
162. Morley J.E., Kaiser F., Raum W.J., Perry H.M., Flood J.F., Jensen J., Silver A.J., Roberts E. Potentially predictive and manipulable blood serum correlates of aging in the healthy human male: progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor 1 to growth hormone. Proc. Natl. Acad. Sci. U.S.A. 94:1997a;7537-7542.
163. Morley J.E., Kaiser F.E., Perry H.M., Patrick P., Morley P.M., Stauber P.M., Vellas B., Baumgartner R.N., Garry P.J. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism. 46:1997b;410-413.
164. Mulnard R.A., Cotman C.W., Kawas C., van Dyck C.H., Sano M., Doody R., Koss E., Pfeiffer E., Jin S., Gamst A., Grundman M., Thomas R., Thal L.J. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. J. Am. Med. Assoc. 283:2000;1007-1015.
165. Murakami K., Fellous A., Baulieu E.E., Robel P. Pregnenolone binds to microtubule-associated protein 2 and stimulates microtubule assembly. Proc. Natl. Acad. Sci. U.S.A. 97:2000;3579-3584.
166. Murialdo G., Nobili F., Rollero A., Gianelli M.V., Copello F., Rodriguez G., Polleri A. Hippocampal perfusion and pituitary-adrenal axis in Alzheimer's disease. Neuropsychobiology. 42:2000;51-57.
167. Mushayandebvu T., Castracane V.D., Gimpel T., Adel T., Santoro N. Evidence for diminished midcycle ovarian androgen production in older reproductive aged women. Fertil. Steril. 65:1996;721-723.
168. Nafziger A.N., Bowlin S.J., Jenkins P.L., Pearson T.A., Melcangi R.C., Celotti F., Ballabio M., Poletti A., Castano P., Martini L., Biegon A., Fischette C.T., Rainbow T.C., McEwen B.S. Longitudinal changes in dehydroepiandrosterone concentrations in men and women. J. Lab. Clin. Med. 131:1998;316-323.
169. Nichols N.R., Zieba M., Bye N. Do glucocorticoids contribute to brain aging? Brain Res. Brain Res. Rev. 37:2001;273-286.
170. Nilsen J., Brinton R.D. Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate. Endocrinology. 143:2002;205-212.
171. Orentreich N., Brind J.L., Rizer R.L., Vogelman J.H. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J. Clin. Endocrinol. Metab. 59:1984;551-555.
172. Ott A., Breteler M.M., van Harskamp F., Stijnen T., Hofman A. Incidence and risk of dementia: the Rotterdam Study. Am. J. Epidemiol. 147:1998;574-580.
173. Padgett D.A., Loria R.M. In vitro potentiation of lymphocyte activation by dehydroepiandrosterone, androstenediol and androstenetriol. J. Immunol. 153:1994;1544-1552.
174. Paganini-Hill A., Henderson V.W. Estrogen deficiency and risk of Alzheimer's disease in women. Am. J. Epidemiol. 140:1994;256-261.
175. Paganini-Hill A., Henderson V.W. Estrogen replacement therapy and risk of Alzheimer disease. Arch. Intern. Med. 156:1996;2213-2217.
176. Pallarés M., Darnaudéry M., Day J., Le Moal M., Mayo W. The neurosteroid pregnenolone sulfate infused into the nucleus basalis increases both acetylcholine release in the frontal cortex or amygdala and spatial memory. Neuroscience. 87:1998;551-558.
177. Papadopoulos V., Guarneri P., Kreuger K.E., Guidotti A., Costa E. Pregnenolone biosynthesis in C6-2B glioma cell mitochondria: regulation by a mitochondrial diazepam binding inhibitor receptor. Proc. Natl. Acad. Sci. U.S.A. 89:1992;5113-5117.
178. Paul S.M., Purdy R.H. Neuroactive steroids. FASEB J. 6:1992;2311-2322.
179. Peters A. Age-related changes in oligodendrocytes in monkey cerebral cortex. J. Comp. Neurol. 371:1996;153-163.
180. Peters A. Structural changes in the normally aging cerebral cortex of primates. Prog. Brain Res. 136:2002;455-465.
181. Peters A., Morrison J.H., Rosene D.L., Hyman B.T. Feature article: are neurons lost from the primate cerebral cortex during normal aging? Cereb. Cortex. 8:1998;295-300.
182. Petersen R.C., Doody R., Kurz A., Mohs R.C., Morris J.C., Rabins P.V., Ritchie K., Rossor M., Thal L., Winblad B. Current concepts in mild cognitive impairment. Arch. Neurol. 58:2001;1985-1992.
183. Phan V.L., Su T.P., Privat A., Maurice T. Modulation of steroidal levels by adrenalectomy/castration and inhibition of neurosteroid synthesis enzymes affect sigma1 receptor-mediated behaviour in mice. Eur. J. Neurosci. 11:1999;2385-2396.
184. Phillips S.M., Sherwin B.B. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology. 17:1992;485-495.
185. Prasad V.V., el-Etr M., Ponticorvo L., Lieberman S. Detection in extracts of bovine brain of lipophilic complexes of sulfate esters of cholesterol and beta-sitosterol. Proc. Natl. Acad. Sci. U.S.A. 82:1985;2657-2659.
186. Rako S. Testosterone deficiency: a key factor in the increased cardiovascular risk to women following hysterectomy or with natural aging? J. Women's Health. 7:1998;825-829.
187. Ravaglia G., Forti P., Maioli F., Boschi F., Bernardi M., Pratelli L., Pizzoferrato A., Gasbarrini G. The relationship of dehydroepiandrosterone sulfate (DHEAS) to endocrine-metabolic parameters and functional status in the oldest-old. Results from an Italian study on healthy free-living over-ninety-year-olds. J. Clin. Endocrinol. Metab. 81:1996;1173-1178.
188. Reddy D.S., Kulkarni S.K. The effects of neurosteroids on acquisition and retention of a modified passive-avoidance learning task in mice. Brain Res. 791:1998;108-116.
189. Resnick S.M., Maki P.M., Golski S., Kraut M.A., Zonderman A.B. Effects of estrogen replacement therapy on PET cerebral blood flow and neuropsychological performance. Horm. Behav. 34:1998;171-182.
190. Rhodes M.E., Li P.K., Burke A.M., Johnson D.A. Enhanced plasma DHEAS, brain acetylcholine and memory mediated by steroid sulfatase inhibition. Brain Res. 773:1997;28-32.
191. Rice M.M., Graves A.B., McCurry S.M., Gibbons L.E., Bowen J.D., McCormick W.C., Larson E.B. Postmenopausal estrogen and estrogen-progestin use and 2-year rate of cognitive change in a cohort of older Japanese American women: the Kame Project. Arch. Intern. Med. 160:2000;1641-1649.
192. Robel, P., Schumacher, M., Baulieu, E.E., 1999. Neurosteroids: from definition and biochemistry to physiological function. In: Baulieu, E.E., Robel, P., Schumacher, M. (Eds.), Neurosteroids. A New Regulatory Function in the Nervous System. Humana Press, Totowa, NJ, pp. 1-25.
193. Robert F., Guennoun R., Desarnaud F., Do-Thi A., Benmessahel Y., Baulieu E.E., Schumacher M. Synthesis of progesterone in Schwann cells: regulation by sensory neurons. Eur. J. Neurosci. 13:2001;916-924.
194. Roe E.B., Chiu K.M., Arnaud C.D. Selective estrogen receptor modulators and postmenopausal health. Adv. Intern. Med. 45:2000;259-278.
195. Romeo E., Cavallaro S., Korneyev A., Kozikowski A.P., Ma D., Polo A., Costa E., Guidotti A. Stimulation of brain steroidogenesis by 2-aryl-indole-3-acetamide derivatives acting at the mitochondrial diazepam-binding inhibitor receptor complex. J. Pharmacol. Exp. Ther. 267:1993;462-471.
196. Rosano G.M., Webb C.M., Chierchia S., Morgani G.L., Gabraele M., Sarrel P.M., de Ziegler, Collins P. Natural progesterone, but not medroxyprogesterone acetate, enhances the beneficial effect of estrogen on exercise-induced myocardial ischemia in postmenopausal women. J. Am. Coll. Cardiol. 36:2000;2154-2159.
197. Rowe J.W., Kahn R.L. Successful aging. Gerontology. 37:1997;433-440.
198. Saaresranta T., Irjala K., Polo K., Polo O. Medroxyprogesterone-induced endocrine alterations after menopause. Menopause. 9:2002;288-292.
199. Saitoh H., Hirato K., Yanaihara T., Nakayama T. A study of 5alpha-reductase in human fetal brain. Endocrinol. Jpn. 29:1982;461-467.
200. Schonknecht P., Pantel J., Klinga K., Jensen M., Hartmann T., von Bergmann K., Beyreuther K., Schroder J. Reduced cerebrospinal fluid estradiol levels are associated with increased beta-amyloid levels in female patients with Alzheimer's disease. Neurosci. Lett. 307:2001;83-85.
201. Schumacher, M., Robert, F., 2002. Progesterone: synthesis, metabolism, mechanisms of action, and effects in the nervous system. In: Pfaff, D.W., Arnold, A.P., Etgen, A.M., Fahrbach, S.E., Rubin, R.T. (Eds.), Hormones, Brain and Behavior, vol. 3. Academic Press, Amsterdam, pp. 683-745.
202. Schumacher M., Hutchison R.E., Hutchison J.B. Inhibition of hypothalamic aromatase activity by 5β-dihydrotestosterone. J. Neuroendocrinol. 3:1991;221-226.
203. Schumacher M., Akwa Y., Guennoun R., Robert F., Labombarda F., Desarnaud F., Robel P., De N., Baulieu E.E. Steroid synthesis and metabolism in the nervous system: trophic and protective effects. J. Neurocytol. 29:2000;307-326.
204. Schumacher M., Guennoun R., Mercier G., Desarnaud F., Lacor P., Benavides J., Ferzaz B., Robert F., Baulieu E.E. Progesterone synthesis and myelin formation in peripheral nerves. Brain Res. Rev. 37:2001;343-359.
205. Serra M., Madau P., Chessa M.F., Caddeo M., Sanna E., Trapani G., Franco M., Liso G., Purdy R.H., Barbaccia M.L., Biggio G. 2-Phenyl-imidazo[1,2-a] pyridine derivatives as ligands for peripheral benzodiazepine receptors: stimulation of neurosteroid synthesis and anticonflict action in rats. Br. J. Pharmacol. 127:1999;177-187.
206. Sih R., Morley J.E., Kaiser F.E., Perry H.M., Patrick P., Ross C. Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J. Clin. Endocrinol. Metab. 82:1997;1661-1667.
207. Simard J., Rheaume E., Mebarki F., Sanchez R., New M.I., Morel Y., Labrie F. Molecular basis of human 3beta-hydroxysteroid dehydrogenase deficiency. J. Steroid Biochem. Mol. Biol. 53:1995;127-138.
208. Sitruk-Ware, R., 2000. Progestins in hormonal replacement therapy and prevention of endometrial disease. In: Sitruk-Ware, R., Mishell, D.R. (Eds.), Progestins and Antiprogestins in Clinical Practice. Marcel Dekker, New York, pp. 269-277.
209. Sitruk-Ware R. Progestogens in hormonal replacement therapy: new molecules, risks, and benefits. Menopause. 9:2002;6-15.
210. Sloane P.D., Zimmerman S., Suchindran C., Reed P., Wang L., Boustani M., Sudha S. The public health impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances. Annu. Rev. Public Health. 23:2002;213-231.
211. Smith Y.R., Giordani B., Lajiness O., Zubieta J.K. Long-term estrogen replacement is associated with improved nonverbal memory and attentional measures in postmenopausal women. Fertil. Steril. 76:2001;1101-1107.
212. Snowdon D.A., Greiner L.H., Mortimer J.A., Riley K.P., Greiner P.A., Markesbery W.R. Brain infarction and the clinical expression of Alzheimer disease: the Nun Study. J. Am. Med. Assoc. 277:1997;813-817.
213. Snyder P.J., Peachey H., Hannoush P., Berlin J.A., Loh L., Holmes J.H., Dlewati A., Staley J., Santanna J., Kapoor S.C., Attie M.F., Haddad J.G., Strom B.L. Effect of testosterone treatment on bone mineral density in men over 65 years of age. J. Clin. Endocrinol. Metab. 84:1999a;1966-1972.
214. Snyder P.J., Peachey H., Hannoush P., Berlin J.A., Loh L., Lenrow D.A., Holmes J.H., Dlewati A., Santanna J., Rosen C.J., Strom B.L. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J. Clin. Endocrinol. Metab. 84:1999b;2647-2653.
215. Sowers M.R., La Pietra M.T. Menopause: its epidemiology and potential association with chronic diseases. Epidemiol. Res. 17:1995;287-302.
216. Steckelbroeck S., Heidrich D.D., Stoffel-Wagner B., Hans V.H., Schramm J., Bidlingmaier F., Klingmuller D. Characterization of aromatase cytochrome P450 activity in the human temporal lobe. J. Clin. Endocrinol. Metab. 84:1999a;2795-2801.
217. Steckelbroeck S., Stoffel-Wagner B., Reichelt R., Schramm J., Bidlingmaier F., Siekmann L., Klingmuller D. Characterization of 17beta-hydroxysteroid dehydrogenase activity in brain tissue: testosterone formation in the human temporal lobe. J. Neuroendocrinol. 11:1999b;457-464.
218. Steckelbroeck S., Watzka M., Reichelt R., Hans V.H., Stoffel-Wagner B., Heidrich D.D., Schramm J., Bidlingmaier F., Klingmuller D. Characterization of the 5alpha-reductase-3alpha-hydroxysteroid dehydrogenase complex in the human brain. J. Clin. Endocrinol. Metab. 86:2001a;1324-1331.
219. Steckelbroeck S., Watzka M., Stoffel-Wagner B., Hans V.H., Redel L., Clusmann H., Elger C.E., Bidlingmaier F., Klingmuller D. Expression of the 17beta-hydroxysteroid dehydrogenase type 5 mRNA in the human brain. Mol. Cell. Endocrinol. 171:2001b;165-168.
220. Steckelbroeck S., Watzka M., Lutjohann D., Makiola P., Nassen A., Hans V.H., Clusmann H., Reissinger A., Ludwig M., Siekmann L., Klingmuller D. Characterization of the dehydroepiandrosterone (DHEA) metabolism via oxysterol 7alpha-hydroxylase and 17-ketosteroid reductase activity in the human brain. J. Neurochem. 83:2002;713-726.
221. Steimer T., Hutchison J.B. Metabolic control of the behavioural action of androgens in the dove brain: testosterone inactivation by 5beta-reduction. Brain Res. 209:1981;189-204.
222. Stein D.G. Brain damage, sex hormones and recovery: a new role for progesterone and estrogen? Trends Neurosci. 24:2001;386-391.
223. Sternbach H. Age-associated testosterone decline in men: clinical issues for psychiatry. Am. J. Psychiatry. 155:1998;1310-1318.
224. Stocco D.M. StAR protein and the regulation of steroid hormone biosynthesis. Annu. Rev. Physiol. 63:2001;193-213.
225. Stoffel-Wagner B., Watzka M., Steckelbroeck S., Ludwig M., Clusmann H., Bidlingmaier F., Casarosa E., Luisi S., Elger C.E., Beyenburg S. Allopregnanolone serum levels and expression of 5alpha-reductase and 3alpha-hydroxysteroid dehydrogenase isoforms in hippocampal and temporal cortex of patients with epilepsy. Epilepsy Res. 54:2003;11-19.
226. Suter U., Nave K.A. Transgenic mouse models of CMT1A and HNPP. Ann. N. Y. Acad. Sci. 883:1999;247-253.
227. Suter U., Snipes G.J. Biology and genetics of hereditary motor and sensory neuropathies. Annu. Rev. Neurosci. 18:1995;45-75.
228. Tang M.X., Jacobs D., Stern Y., Marder K., Schofield P., Gurland B., Andrews H., Mayeux R. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 348:1996;429-432.
229. Tanzer L., Jones K.J. Gonadal steroid regulation of hamster facial nerve regeneration: effects of dihydrotestosterone and estradiol. Exp. Neurol. 146:1997;258-264.
230. Tenover J.S. Effects of testosterone supplementation in the aging male. J. Clin. Endocrinol. Metab. 75:1992;1092-1098.
231. Thomas A.J., Nockels R.P., Pan H.Q., Shaffrey C.I., Chopp M. Progesterone is neuroprotective after acute experimental spinal cord trauma in rats. Spine. 24:1999;2134-2138.
232. Trapani G., Franco M., Latrofa A., Ricciardi L., Carotti A., Serra M., Sanna E., Biggio G., Liso G. Novel 2-phenylimidazo[1,2-a]pyridine derivatives as potent and selective ligands for peripheral benzodiazepine receptors: synthesis, binding affinity, and in vivo studies. J. Med. Chem. 42:1999;3934-3941.
233. Tsutsui K., Ukena K., Usui M., Sakamoto H., Takase M. Novel brain function: biosynthesis and actions of neurosteroids in neurons. Neurosci. Res. 36:2000;261-273.
234. Twist S.J., Taylor G.A., Weddell A., Weightman D.R., Edwardson J.A., Morris J.A. Brain oestradiol and testosterone levels in Alzheimer's disease. Neurosci. Lett. 286:2000;1-4.
235. Urani A., Privat A., Maurice T. The modulation by neurosteroids of the scopolamine-induced learning impairment in mice involves an interaction with sigma1 (σ1) receptors. Brain Res. 799:1998;64-77.
236. Uzunov D.P., Cooper T.B., Costa E., Guidotti A. Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography. Proc. Natl. Acad. Sci. U.S.A. 93:1996;12599-12604.
237. Vallée M., Mayo W., Darnaudery M.C.C., Young J., Koehl M.L.M.M., Baulieu E.E., Robel P., Simon H. Neurosteroids: deficient cognitive performance in aged rats depends on low pregnenolone sulfate levels in hippocampus. Proc. Natl. Acad. Sci. U.S.A. 94:1997;14865-14870.
238. Vallée M., Mayo W., Le M. Role of pregnenolone, dehydroepiandrosterone and their sulfate esters on learning and memory in cognitive aging. Brain Res. Rev. 37:2001;301-312.
239. van den Beld, A.W., Lamberts, S.W.J., 2002. Endocrine aspects of healthy ageing in men. In: Chadwick, D.J., Goode, J.A. (Eds.), Endocrine Facets of Ageing. Proceedings of the Novartis Foundation Symposium, vol. 242. Wiley, Chichester, UK, pp. 3-16.
240. Vermeulen A. Clinical review 24: androgens in the aging male. J. Clin. Endocrinol. Metab. 73:1991;221-224.
241. Vermeulen A., Verdonck L. Radioimmunoassay of 17beta-hydroxy-5alpha- androstan-3-one, 4-androstene-3,17-dione, dehydroepiandrosterone, 17-hydroxyprogesterone and progesterone and its application to the human male plasma. J. Steroid Biochem. 7:1976;1-10.
242. Verwer R.W., Dubelaar E.J., Hermens W.T., Swaab D.F. Tissue cultures from adult human postmortem subcortical brain areas. J. Cell. Mol. Med. 6:2000;429-432.
243. Wakatsuki A., Okatani Y., Ikenoue N., Fukaya T. Effect of medroxyprogesterone acetate on endothelium-dependent vasodilation in postmenopausal women receiving estrogen. Circulation. 104:2001;1773-1778.
244. Wang M.D., Wahlström G., Bäckström T. The regional brain distribution of the neurosteroids pregnenolone and pregnenolone sulfate following intravenous infusion. J. Steroid Biochem. Mol. Biol. 62:1997;299-306.
245. Wang P.N., Liao S.Q., Liu R.S., Liu C.Y., Chao H.T., Lu S.R., Yu H.Y., Wang S.J., Liu H.C. Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study. Neurology. 54:2000;2061-2066.
246. Watzka M., Bidlingmaier F., Schramm J., Klingmuller D., Stoffel-Wagner B. Sex-and age-specific differences in human brain CYP11A1 mRNA expression. J. Neuroendocrinol. 11:1999;901-905.
247. Weill-Engerer S., David J.P., Sazdovitch V., Liere P., Eychenne B., Pianos A., Schumacher M., Delacourte A., Baulieu E.E., Akwa Y. Neurosteroid quantification in human brain regions: comparison between Alzheimer's and non-demented patients. J. Clin. Endocrinol. Metab. 87:2002;5138-5143.
248. Weill-Engerer S., David J.P., Sazdovitch V., Liere P., Schumacher M., Delacourte A., Baulieu E.E., Akwa Y. In vitro metabolism of dehydroepiandrosterone (DHEA) to 7α-hydroxy-DHEA and Δ5-androstene- 3β,17β-diol in specific regions of the aging brain from Alzheimer's and non-demented patients. Brain Res. 969:2003;117-125.
249. West M.J., Kawas C.H., Martin L.J., Troncoso J.C. The CA1 region of the human hippocampus is a hot spot in Alzheimer's disease. Ann. N. Y. Acad. Sci. 908:2000;255-259.
250. Whitaker M.D. Selective estrogen receptor modulators: from bench to bedside and back. Endocr. Pract. 7:2001;113-119.
251. White P.C., Grossberger D., Onufer B.J., Chaplin D.D., New M.I., Dupont B., Strominger J.L. Two genes encoding steroid 21-hydroxylase are located near the genes encoding the fourth component of complement in man. Proc. Natl. Acad. Sci. U.S.A. 82:1985;1089-1093.
252. Wickelgren I. For the cortex, neuron loss may be less than thought. Science. 273:1996a;48-50.
253. Wickelgren I. Is hippocampal cell death a myth? Science. 271:1996b;1229-1230.
254. Winters S.J. Current status of testosterone replacement therapy in men. Arch. Fam. Med. 8:1999;257-263.
255. Wise P.M., Smith M.J., Dubal D.B., Wilson M.E., Krajnak K.M., Rosewell K.L. Neuroendocrine influences and repercussions of the menopause. Endocr. Rev. 20:1999;243-248.
256. Wise P.M., Dubal D.B., Wilson M.E., Rau S.W. Estradiol is a neuroprotective factor in in vivo and in vitro models of brain injury. J. Neurocytol. 29:2000;401-410.
257. Wise P.M., Dubal D.B., Wilson M.E., Rau S.W., Bottner M., Rosewell K.L. Estradiol is a protective factor in the adult and aging brain: understanding of mechanisms derived from in vivo and in vitro studies. Brain Res. Brain Res. Rev. 37:2001;313-319.
258. Wolf O.T., Neumann O., Hellhammer D.H., Geiben A.C., Strasburger C.J., Dressendorfer R.A., Pirke K.M., Kirschbaum C. Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men. J. Clin. Endocrinol. Metab. 82:1997;2363-2367.
259. Wolkowitz O.M., Reus V.I., Roberts E., Manfredi F., Chan T., Ormiston S., Johnson R., Canick J., Brizendine L., Weingartner H. Antidepressant and cognition-enhancing effects of DHEA in major depression. Ann. N. Y. Acad. Sci. 774:1995;337-339.
260. Women's Health Initiative Investigators, 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. J. Am. Med. Assoc. 288, 321-333.
261. Women's Health Initiative Investigators, 2003a. Effect of estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. J. Am. Med. Assoc. 289, 2651-2662.
262. Women's Health Initiative Investigators, 2003b. Effect of estrogen plus progestin on global cognitive function in postmenopausal women. J. Am. Med. Assoc. 289, 2663-2672.
263. Women's Health Initiative Investigators, 2003c. Effect of estrogen plus progestin on stroke in postmenopausal women. J. Am. Med. Assoc. 289, 2673-2684.
264. Women's Health Initiative Investigators, 2003d. Effects of estrogen plus progestin on health-related quality of life. N. Engl. J. Med. 348, 1839-1854.
265. Wozniak A., Hutchison R.E., Morris C.M., Hutchison J.B. Neuroblastoma and Alzheimer's disease brain cells contain aromatase activity. Steroids. 63:1998;263-267.
266. Xu H., Gouras G.K., Greenfield J.P., Vincent B., Naslund J., Mazzarelli L., Fried G., Jovanovic J.N., Seeger M., Relkin N.R., Liao F., Checler F., Buxbaum J.D., Chait B.T., Thinakaran G., Sisodia S.S., Wang R., Greengard P., Gandy S. Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nat. Med. 4:1998;447-451.
267. Yaffe K. Estrogens, selective estrogen receptor modulators, and dementia: what is the evidence? Ann. N. Y. Acad. Sci. 949:2001;215-222.
268. Yaffe K. Hormone therapy and the brain. J. Am. Med. Assoc. 289:2003;2717-2719.
269. Yaffe K., Ettinger B., Pressman A., Seeley D., Whooley M., Schaefer C., Cummings S. Neuropsychiatric function and dehydroepiandrosterone sulfate in elderly women: a prospective study. Biol. Psychiatry. 43:1998a;694-700.
270. Yaffe K., Sawaya G., Lieberburg I., Grady D. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. J. Am. Med. Assoc. 279:1998b;688-695.
271. Yanase T., Fukahori M., Taniguchi S., Nishi Y., Sakai Y., Takayanagi R., Haji M., Nawata H. Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEA-S) in Alzheimer's disease and in cerebrovascular dementia. Endocr. J. 43:1996;119-123.
272. Yu W.H. Survival of motoneurons following axotomy is enhanced by lactation or by progesterone treatment. Brain Res. 491:1989;379-382.
273. Yu L., Romero D.G., Gomez-Sanchez C.E., Gomez-Sanchez E.P. Steroidogenic enzyme gene expression in the human brain. Mol. Cell. Endocrinol. 190:2002;9-17.
274. Zhang L., Rubinow D.R., Xaing G., Li B.S., Chang Y.H., Maric D., Barker J.L., Ma W. Estrogen protects against beta-amyloid-induced neurotoxicity in rat hippocampal neurons by activation of Akt. Neuroreport. 12:2001;1919-1923.
275. Zwain I.H., Yen S.S. Dehydroepiandrosterone: biosynthesis and metabolism in the brain. Endocrinology. 140:1999a;880-887.
276. Zwain I.H., Yen S.S. Neurosteroidogenesis in astrocytes, oligodendrocytes, and neurons of cerebral cortex of rat brain. Endocrinology. 140:1999b;3843-3852.
277. Zumoff B., Strain G.W., Miller L.K., Rosner W. Twenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women. J. Clin. Endocrinol. Metab. 80:1995;1429-1430.